Hormone therapy (HRT)

Oral vs Patch vs Cream Estradiol: Which Form of Estrogen Fits You?

The short answer

Estradiol tablets, patches, gels and creams all relieve hot flashes, but the route changes how estradiol is processed. Pills pass through the liver first, and in a large UK study oral HRT was linked to a higher risk of blood clots (odds ratio 1.58) while patches and gels were not (0.93). A clinician weighs your health history, preferences and risk factors to choose a route.

The ways to take estradiol, at a glance

Estradiol is the main estrogen your ovaries make before menopause, and it is the hormone in most modern hormone therapy. What differs from one prescription to the next is mostly the route: how the estradiol gets into your body.

FormHow it's usedHow it reaches your bloodMain things to know
Tablet you swallowUsually once a dayThrough the gut, then the liver, before the rest of the bodySimple and familiar; liver "first pass" changes some blood proteins
PatchChanged once or twice a weekThrough the skin, straight into the bloodstreamSteady levels; can irritate skin or fall off
Gel or sprayDaily, on the arm or thighThrough the skinNeeds to dry; wash your hands after applying
Cream on the skinDailyThrough the skinUsually compounded for whole-body use; absorption varies
Dissolving tablet (sublingual or buccal)Often more than once a dayThrough the lining of the mouth, plus whatever is swallowedFast rise and fall in levels; less long-term research
Vaginal cream, tablet or ringDaily to every few monthsMostly stays in vaginal and urinary tissueFor dryness and painful sex, not hot flashes

Pills, patches, gels, skin creams and dissolving tablets are all systemic: they raise estrogen throughout the body to treat hot flashes, night sweats and sleep disruption. Low-dose vaginal products are local. If dryness is your only symptom, read local vs systemic HRT.

Why the route matters: the liver's "first pass"

When you swallow an estradiol tablet, it is absorbed from the gut and carried to the liver before it reaches the rest of your body. The liver converts much of it to estrone, a weaker estrogen, and responds to the high local dose by making more of certain proteins (Kuhl 2005). These include:

  • Clotting factors, which is the leading explanation for the higher blood clot risk with pills
  • Sex hormone-binding globulin (SHBG), which binds testosterone and estradiol and can lower the amount that is free and active
  • Triglycerides, a blood fat that tends to rise with oral estrogen

Patches, gels and creams on the skin skip that first trip through the liver, so these changes are much smaller. Oral estrogen does have some favorable liver effects too, such as lowering LDL cholesterol, so "transdermal is better" isn't true for every woman (The Menopause Society 2022).

Blood clots and stroke: what the studies show

Blood clots in the legs or lungs (venous thromboembolism, or VTE) are the risk that differs most between routes. No large randomized trial has compared pills and patches head to head for clots, so the evidence comes from big observational studies. They point in the same direction.

By the numbers

Blood clot and stroke risk by route of estrogen

1.58odds of a blood clot with oral HRT vs no HRT, in 80,396 UK women with clotsSource: Vinogradova 2019
0.93odds of a blood clot with patches or gels: no increase seenSource: Vinogradova 2019
4.2 vs 0.9clot odds for oral vs transdermal estrogen in the French ESTHER studySource: Canonico 2007
0.81stroke rate ratio with low-dose patches, vs 1.28 with oral HRTSource: Renoux 2010

Some details matter. In the UK study, oral estradiol carried less clot risk than conjugated equine estrogens (the hormone in Premarin), and the combination of conjugated estrogens with medroxyprogesterone acetate had the highest risk (Vinogradova 2019). In the stroke study, high-dose patches did raise stroke risk, so the advantage applied to standard and lower doses (Renoux 2010).

Keep the scale in mind. These are relative numbers. For a healthy woman in her late 40s or 50s, the absolute chance of a clot is low to begin with. The Menopause Society concludes that for women under 60, or within 10 years of their last period, without reasons to avoid hormones, the benefits of hormone therapy generally outweigh the risks, and that skin routes may carry lower clot and stroke risk than oral ones (The Menopause Society 2022).

Do they work equally well for symptoms?

Yes, broadly. Hormone therapy is the most effective treatment available for hot flashes and night sweats. A Cochrane review of 24 randomized trials found oral hormone therapy cut weekly hot flash frequency by about 75% compared with placebo (MacLennan 2004). Patches, gels and sprays at equivalent doses also relieve vasomotor symptoms, and guidelines don't rank one systemic route as stronger than another for symptom relief (The Menopause Society 2022).

What changes is the day-to-day experience. Some women feel the difference between steady levels from a patch and the daily rise and fall of a tablet; many don't. If one route doesn't suit you, a different route at the right dose often does.

Creams: FDA-approved vs compounded

"Estradiol cream" can mean two very different things.

  • FDA-approved estradiol vaginal cream (Estrace) is labeled for vaginal and vulvar atrophy: dryness, irritation and pain with sex (Estrace label). It is applied in the vagina, mostly for local effect.
  • Estradiol creams rubbed on the skin for whole-body symptoms are usually compounded: mixed by a pharmacy for an individual prescription. FDA-approved skin products for systemic use are mostly patches, gels and a spray.

Compounded hormones aren't FDA-approved, which means they haven't gone through the same testing for consistent dose and absorption. A 2020 National Academies report and ACOG's 2023 guidance both recommend FDA-approved hormone therapy when it meets a woman's needs, and compounded products when there is a specific reason, such as an allergy to an ingredient or a dose or form that isn't commercially available (NASEM 2020, ACOG 2023). For the bigger picture, see bioidentical hormones.

Which route might suit you?

There is no single best form. These are the trade-offs clinicians and women most often weigh.

A tablet may suit you if

  • You'd rather take a pill than wear or apply something
  • Patches have irritated your skin or won't stay on
  • You don't have extra risk factors for clots

A patch or gel may suit you if

  • You have risk factors that make clot or stroke risk more of a concern, since large observational studies link patches and gels with lower clot risk than tablets (Vinogradova 2019)
  • You've had side effects like nausea on oral estrogen
  • You prefer steadier levels and fewer doses

A dissolving tablet

Sublingual (under the tongue) and buccal (between cheek and gum) estradiol sit somewhere in between: estradiol is absorbed through the lining of the mouth, but research on long-term safety is much thinner than for pills and patches. We cover it in detail in sublingual estradiol.

Don't forget progesterone

Whatever the route, if you still have a uterus, systemic estrogen needs to be paired with a progestogen to protect the uterine lining from overgrowth. Micronized progesterone is the body-identical option most women are offered today. Read why estradiol and progesterone go together for how that works and how the different progestogens compare.

Where Amie HRT+ fits

Amie HRT+ is a compounded prescription of estradiol and progesterone. A licensed clinician reviews your symptoms, health history and medications, decides whether hormone therapy is appropriate for you, and chooses the strength. Compounded medications are not FDA-approved, and your clinician can talk through FDA-approved alternatives, including patches and gels, if one of those fits you better.

Questions to ask before you choose

  • Do I have any risk factors that make a skin route a better choice for me?
  • Do I need progesterone, and which kind?
  • What dose are we starting with, and when will we review it?
  • What side effects should make me call you?
  • Is this product FDA-approved or compounded, and why this one?

If you're preparing for an appointment, our guide on how to talk to your doctor about menopause can help.

Medically reviewed by

Dr. Jessica Russell, MD

Obstetrician-gynecologist · Reviewed November 5, 2026

NPI 1447397583 · verify

Common questions

Is the estradiol patch safer than the pill?

For blood clots and stroke, observational studies suggest skin routes (patches and gels) carry less risk than pills, especially at standard doses. For most healthy women under 60 or within 10 years of menopause, The Menopause Society considers either route reasonable. Your own risk factors matter most.

Do estradiol pills and patches work equally well for hot flashes?

Both are effective. Hormone therapy is the most effective treatment for hot flashes and night sweats, and the choice between routes is usually about safety profile, convenience and preference rather than strength of relief.

Is estradiol cream the same as an estradiol patch?

No. The FDA-approved estradiol cream in the US is a vaginal cream for local dryness and pain with sex. Estradiol creams rubbed on the skin for whole-body symptoms are usually compounded, and how much estradiol they deliver can vary.

Do I still need progesterone with an estradiol patch?

Yes, if you have a uterus. Any estrogen that reaches the whole body, whether a pill, patch, gel, cream or dissolving tablet, needs a progestogen such as progesterone to protect the uterine lining.

Can I switch from estradiol pills to a patch?

Often, yes. Clinicians switch routes for reasons like side effects, skin irritation, clot risk factors or preference. Don't change on your own; your prescriber will pick an equivalent dose and tell you how to switch.

Sources

  1. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022
  2. Vinogradova Y et al. Use of hormone replacement therapy and risk of venous thromboembolism (QResearch and CPRD). BMJ 2019
  3. Canonico M et al. Hormone therapy and venous thromboembolism: the ESTHER study. Circulation 2007
  4. Renoux C et al. Transdermal and oral hormone replacement therapy and the risk of stroke. BMJ 2010
  5. MacLennan AH et al. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004
  6. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 2005
  7. Estrace (estradiol vaginal cream) prescribing information, DailyMed
  8. ACOG Clinical Consensus No. 6: Compounded Bioidentical Menopausal Hormone Therapy (2023)
  9. National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy. 2020

Amie prescribes in all 50 states. Find online hrt in your state.